Dynamic RMST curves for survival analysis in clinical trials
The data from immuno-oncology (IO) therapy trials often show delayed effects, cure rate, crossing hazards, or some mixture of these phenomena. Thus, the proportional hazards (PH) assumption is often violated s...
Source: BMC Medical Research Methodology - Category: Research Authors: Jason J. Z. Liao, G. Frank Liu and Wen-Chi Wu Tags: Technical advance Source Type: research